- Home
- NNOX vs COYA Comparison
NNOX vs COYA Comparison
Compare NNOX & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNOX | COYA |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 126.6M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | NNOX | COYA |
|---|---|---|
| Price | $2.26 | $4.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $7.00 | ★ $15.80 |
| AVG Volume (30 Days) | ★ 1.3M | 250.4K |
| Earning Date | 03-30-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,302,000.00 | $3,987,706.00 |
| Revenue This Year | $20.19 | $70.00 |
| Revenue Next Year | $137.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.19 | N/A |
| 52 Week Low | $2.11 | $3.94 |
| 52 Week High | $7.60 | $8.29 |
Technical Indicators
Market Signals| Indicator | NNOX | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 33.13 | 48.92 |
| Support Level | $2.11 | $4.41 |
| Resistance Level | $2.50 | $5.32 |
| Average True Range (ATR) | 0.20 | 0.30 |
| MACD | -0.05 | 0.06 |
| Stochastic Oscillator | 9.91 | 46.70 |
Price Performance
Historical ComparisonAbout NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.